Form 8-K - Current report:
SEC Accession No. 0001140361-24-039083
Filing Date
2024-08-29
Accepted
2024-08-29 07:21:47
Documents
16
Period of Report
2024-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20035097_8k.htm   iXBRL 8-K 36580
2 EXHIBIT 99.1 ef20035097_ex99-1.htm EX-99.1 15879
6 graphic1.jpg GRAPHIC 9470
7 logo1.jpg GRAPHIC 6366
  Complete submission text file 0001140361-24-039083.txt   219239

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20240828.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20240828_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20240828_pre.xml EX-101.PRE 16050
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20035097_8k_htm.xml XML 4442
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 241258619
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)